Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/223114
Patient Stratification for Serum LDH Levels Reveals Distinct CLA+ T-Cell Cytokine Secretion in Response to HDM, Clinical Features and Allergic Comorbidities
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Lactate dehydrogenase (LDH) is a serum biomarker well known to correlate with disease severity in atopic dermatitis (AD). The aim of this study was to explore the cutaneous immune responses and the clinical profile of AD patients in relation to serum LDH levels. To this end, 47 untreated, adult patients with moderate-to-severe AD were stratified by median levels of serum LDH. Circulating memory T-cell responses to house dust mite (HDM) extract, in the presence of autologous lesional epidermal cells, were compared between AD subgroups. The LDHhigh group exhibited significantly higher IL-13, IL-5 and IL-9 in vitro responses confined to the cutaneous lymphocyte-associated antigen (CLA)+ subset compared to LDHlow patients. Clinically, LDHhigh patients were younger and exhibited more severe disease, elevated eosinophil counts in their blood, increased total and specific IgE levels in their plasma, and a higher prevalence of allergic rhinitis. Our data suggests that high LDH levels identify a subgroup of AD patients with a specific immune and clinical profile, and highlight the potential of LDH as a clinical parameter that may enable patient stratification for treatment selection.
Matèries
Matèries (anglès)
Citació
Citació
GARCÍA JIMÉNEZ, Irene, FIGUERAS NART, Ignasi, SANS DE SAN NICOLÀS, Lídia, CURTO BARREDO, Laia, BERTOLÍN COLILLA, Marta, BONFILL ORTÍ, Montserrat, DÍEZ RIBAS, Sandra, LLOBET DEL PINO, Alex, GUILABERT VIDAL, Antonio, RYZHKOVA, Anna, FERRAN, Marta, PUJOL, Ramon m., SANTAMARIA BABÍ, Luis f.. Patient Stratification for Serum LDH Levels Reveals Distinct CLA+ T-Cell Cytokine Secretion in Response to HDM, Clinical Features and Allergic Comorbidities. _International Journal of Molecular Sciences_. 2025. Vol. 26, núm. 16, pàgs. 7821. [consulta: 23 de gener de 2026]. ISSN: 1422-0067. [Disponible a: https://hdl.handle.net/2445/223114]